32186 Federal Register / Vol. 75, No. 108 / Monday, June 7, 2010 / Notices 

federally-funded research and 

development. Foreign patent 

applications are filed on selected 

inventions to extend market coverage 

for companies and may also be available 

for licensing. 

ADDRESSES: Licensing information and 

copies of the U.S. patent applications 

listed below may be obtained by writing 

to the indicated licensing contact at the 

Office of Technology Transfer, National 

Institutes of Health, 6011 Executive 

Boulevard, Suite 325, Rockville, 

Maryland 20852–3804; telephone: 301/ 

496–7057; fax: 301/402–0220. A signed 

Confidential Disclosure Agreement will 

be required to receive copies of the 

patent applications. 

Software System for Analysis of 

Extremely Large Experimental Dataset 

and Multidimensional Drug Discovery 

Description of Invention: This 

invention is a computer software suite 

that will enable its user to investigate 

extremely large experimental datasets in 

a simple yet multidimensional manner. 

The software, Omnimorph, allows 

multidimensional investigation of any 

form of data including experimental 

datasets in biomedical science using 

either gene arrays or proteomics. 

Omnimorph allows the user to look for 

extremely subtle correlated differences 

between experimental datasets which 

will allow the investigator to discover 

far more drug- or disease-specific factors 

than other analytical methods currently 

used. The software of present invention 

has been employed in the targeted 

discovery of G protein-independent 

receptor-based pharmacotherapeutics. 

These discoveries represent an entirely 

new GPCR-based G protein-independent 

pharmacopeia. Therefore, the 

Omnimorph is not only newly 

developed software, but the Omnimorph 

suite can also be used as a simple and 

unbiased tool to detect novel and 

unexpected modes of GPCR-based drug 

actions. This could potentially alter the 

way drugs are developed and screened 

in the future. 

Applications: 

• Development and screen for 

pharmaceutical drugs. 

• Biomedical research. 

Development Status: 

• The invention has been fully 

developed. 

• The software will be readily 

available if so requested. 

Inventors: Stuart R. Maudsley et al. 

(NIA). 

Patent Status: HHS Reference No. E– 

143–2010/0—Research Tool. Patent 

protection is not being pursued for this 

technology. 

Licensing Status: Available for 

licensing. 

Licensing Contacts: Uri Reichman, 

PhD, MBA; 301–435–4616; 

UR7a@nih.gov; or Michael Shmilovich, 

Esq.; 301–435–5019; 

ShmilovichM@mail.nih.gov. 

Collaborative Research Opportunity: 

The National Institute on Aging, 

Laboratory of Neurosciences-Receptor 

Pharmacology Unit, is seeking 

statements of capability or interest from 

parties interested in collaborative 

research to further develop, evaluate, or 

commercialize this technology. Please 

contact John Hewes, PhD at 301–435– 

3131 or hewesj@mail.nih.gov for more 

information. 

Sound Attenuation Canopy for 

Reducing Noise Transmitted Through 

Suspended Ceilings 

Description of Invention: Available for 

licensing and commercial 

implementation in commercial facilities 

design and construction are intellectual 

property rights covering a sound 

attenuation canopy for reducing noise 

transmitted through suspended ceiling 

systems commonly used in most office 

buildings. The canopy is designed to 

absorb sound energy and effectively 

reduce the direct path of sound 

travelling within open plenum 

suspended ceilings like those used in 

most office building environments. The 

canopy can also act as an umbrella to 

shield loose debris and dust which may 

be located in the plenum and 

potentially fall when ceiling suspended 

return-air grilles are moved or accessed. 

The canopy has an added benefit of 

reducing heating or cooling loss which 

may naturally ventilate through the 

return air plenum grille from a 

conditioned office space below. Also, 

the canopy controls leakage of heating 

and cooling, reducing loads on the 

central building systems thereby 

lessening energy costs and extending 

the life-cycle of the building’s physical 

plant. 

The canopy does not impede natural 

air flow for ventilating the plenum 

cavity but deters the spread of smoke or 

fire between the plenum and the office 

space below. The canopy can also act as 

a secondary air balancer or K Factor 

balancer to equate supply and return air 

to control room temperature. The 

canopy is pliable and therefore allows 

for ease of adjustment within varying 

plenum conditions as well as readily 

installed in ceiling plenums. 

Applications: 

• Building design and construction. 

• Sound attenuation. 

• Energy load reduction. 

Inventors: Judit A. Quasney, Franklin 

Koh, John P. Jenkins, Robert M. 

Alexander, Daniel P. O’Brien (NIAID). 

Patent Status: U.S. Patent Application 

No. 12/764,872 filed 21 Apr 2010 (HHS 

Reference No. E–102–2010/0–US–01) 

Licensing Status: Available for 

licensing. 

Licensing Contact: Michael A. 

Shmilovich, Esq.; 301–435–5019; 

shmilovm@mail.nih.gov. 

Dated: June 1, 2010. 

Richard U. Rodriguez, 

Director, Division of Technology Development 

and Transfer, Office of Technology Transfer, 

National Institutes of Health. 

[FR Doc. 2010–13597 Filed 6–4–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Task Force on Community Preventive 

Services 

Name: Task Force on Community 

Preventive Services meeting. 

Times and Dates: 8 a.m.–5:30 p.m. 

EST, June 16, 2010. 8 a.m.–1 p.m. EST, 

June, 17, 2010. 

Place: Centers for Disease Control and 

Prevention, 2500 Century Center, 

Atlanta, GA 30329. 

Status: Open to the public, limited 

only by space available. 

Purpose: The mission of the Task 

Force is to develop and publish the 

Guide to Community Preventive 

Services (Community Guide), which is 

based on the best available scientific 

evidence and current expertise 

regarding essential public health and 

what works in the delivery of those 

services. 

Matters to be discussed: (1) Updates 

of prior reviews on the following topics: 

Reducing Vaccine-Preventable Diseases; 

Increasing Screening for Breast, 

Cervical, and Colorectal Cancer. 

(2) New reviews on: Immunization 

Information Systems; Collaborative Care 

for the Management of Depressive 

Disorders and Communication 

Campaigns with Product Distribution. 

Agenda items are subject to change as 

priorities dictate. 

Contact person or additional 

information: Freda Parker, Community 

Guide Branch, Centers for Disease 

Control and Prevention, 1600 Clifton 

Road, M/S E–69, Atlanta, GA 30333, 

phone: 404.498.1119. 

WReier-Aviles on DSKGBLS3C1PROD with NOTICES

Federal Register / Vol. 75, No. 108 / Monday, June 7, 2010 / Notices 32187 

Dated: May 28, 2010. 

Tanja Popovic, 

Associate Director for Science, Centers for 

Disease Control and Prevention. 

[FR Doc. 2010–13514 Filed 6–4–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Research 

Resources: Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Center for 

Research Resources Special Emphasis Panel; 

CTSA Renewal. 

Date: October 13–14, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Rockville, 1750 Rockville 

Pike, Rockville, MD 20852. 

Contact Person: Mohan Viswanathan, PhD, 

Deputy Director, Office of Review, National 

Center for Research Resources, National 

Institutes of Health, 6701 Democracy Blvd., 

Dem. 1, Room 1084, MSC 4874, Bethesda, 

MD 20892–4874, 301–435–0829, 

mv10f@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research; 93.371, Biomedical 

Technology; 93.389, Research Infrastructure; 

93.306, 93.333; 93.702, ARRA Related 

Construction Awards, National Institutes of 

Health, HHS) 

Dated: June 1, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–13582 Filed 6–4–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Research 

Resources; Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Center for 

Research Resources Special Emphasis Panel; 

NCRR SBIR2 Contract Review. 

Date: June 30, 2010. 

Time: 8 a.m. to 12 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: Bethesda Marriott Suites, 6711 

Democracy Blvd., Executive Board Room, 

Bethesda, MD 20817. 

Contact Person: Guo Zhang, PhD, MD, 

Scientific Review Administrator, National 

Center for Research Resources, or National 

Institutes of Health, 6701 Democracy 

Boulevard, 1 Democracy Plaza, Room 1064, 

MSC 4874, Bethesda, MD 20892–4874, 301– 

435–0812, zhanggu@mail.nih.gov. 

Name of Committee: National Center for 

Research Resources Special Emphasis Panel; 

Conference Grants 2010. 

Date: July 15, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, One 

Democracy Plaza, 6701 Democracy 

Boulevard, Bethesda, MD 20892. 

Contact Person: Lee Warren Slice, PhD, 

Scientific Review Officer, Office of Review, 

National Center for Research Resources, 

Bethesda, MD 20892, 301–435–0965. 

Name of Committee: National Center for 

Research Resources Special Emphasis Panel. 

Date: July 20, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Rockville, 1750 Rockville 

Pike, Rockville, MD 20852. 

Contact Person: Sheri A. Hild, PhD, 

Scientific Review Officer, National Institutes 

of Health, National Center for Research 

Resources, Office of Review, 6701 Democracy 

Blvd, Rm. 1082, Bethesda, MD 20892, 301– 

435–0811, hildsa@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research; 93.371, Biomedical 

Technology; 93.389, Research Infrastructure; 

93.306, 93.333; 93.702, ARRA Related 

Construction Awards, National Institutes of 

Health, HHS) 

Dated: June 1, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–13579 Filed 6–4–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Research 

Resources; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Center for 

Research Resources Special Emphasis Panel. 

Date: July 13, 2010. 

Time: 1 p.m. to 2 p.m 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Democracy II, 6701 Democracy Blvd., 1074, 

Bethesda, MD 20892. 

Contact Person: Lisa A. Newman, SCD, 

Scientific Review Officer, National Institutes 

of Health, National Center for Research 

Resources, Office of Review, Room 1074, 

6701 Democracy Blvd., MSC 4874, Bethesda, 

MD 20892, 301–435–0965, 

newmanla2@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research; 93.371, Biomedical 

Technology; 93.389, Research Infrastructure; 

93.306, 93.333, 93.702, ARRA Related 

Construction Awards, National Institutes of 

Health, HHS) 

Dated: June 1, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–13576 Filed 6–4–10; 8:45 am] 

BILLING CODE 4140–01–P 

WReier-Aviles on DSKGBLS3C1PROD with NOTICES